This session provides a focused, case-based review of sedative-hypnotic use disorders and their management across clinical settings, including key concepts in pharmacology, diagnosis, and patterns of use and misuse, aligned with the ACAAM National Addiction Medicine Didactic Curriculum and ABPM content areas.
What This Covers• Pharmacology of sedative-hypnotic agents, including benzodiazepines, Z-drugs, and other sedatives• Patterns of use, misuse, and identification of high-risk patients• Recognition and management of sedative intoxication and withdrawal• Risk stratification and identification of severe withdrawal syndromes• Practical approaches to detoxification and withdrawal management• Medication selection and tapering strategies across inpatient and outpatient settings• Clinical decision-making for safe and effective management of sedative-hypnotic use disorders• Integration of care across treatment settings to improve patient outcomes
How This Resource Is UsedThis session is designed for on-demand learning and targeted content review. It can be used to reinforce specific knowledge areas or as part of structured board preparation.
Elizabeth F. Howell, MD MS
Dr. Howell is Professor of Psychiatry (Clinical) at the University of Utah School of Medicine and serves as Training Director for the Addiction Psychiatry fellowship and Associate Training Director for Addiction Medicine fellowship. She provides clinical care at the Huntsman Mental Health Institute and University of Utah Hospital and is board certified in Psychiatry, Addiction Psychiatry, and Addiction Medicine.
To support a meaningful learning experience and recognize your participation: